| Cardiovascular risk factors and disease after male germ cell cancer J Lauritsen, MK Hansen, M Bandak, MB Kreiberg, JW Skøtt, T Wagner, ... Journal of Clinical Oncology 38 (6), 584-592, 2020 | 78 | 2020 |
| Beta2‐adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men M Hostrup, S Reitelseder, S Jessen, A Kalsen, M Nyberg, J Egelund, ... The Journal of physiology 596 (17), 4121-4139, 2018 | 51 | 2018 |
| Late adverse effects and quality of life in survivors of testicular germ cell tumour M Chovanec, J Lauritsen, M Bandak, C Oing, GG Kier, M Kreiberg, ... Nature Reviews Urology 18 (4), 227-245, 2021 | 50 | 2021 |
| Sexual function in a nationwide cohort of 2,260 survivors of testicular cancer after 17 years of followup M Bandak, J Lauritsen, C Johansen, M Kreiberg, JW Skøtt, M Agerbaek, ... The Journal of urology 200 (4), 794-800, 2018 | 32 | 2018 |
| Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men J Onslev, G Jacobson, C Narkowicz, V Backer, A Kalsen, M Kreiberg, ... European journal of applied physiology 117, 1907-1915, 2017 | 28 | 2017 |
| Psychological stress in long-term testicular cancer survivors: a Danish nationwide cohort study M Kreiberg, M Bandak, J Lauritsen, KK Andersen, JW Skøtt, C Johansen, ... Journal of Cancer Survivorship 14, 72-79, 2020 | 20 | 2020 |
| β2-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance … S Jessen, S Reitelseder, A Kalsen, M Kreiberg, J Onslev, A Gad, ... Journal of Applied Physiology 130 (3), 617-626, 2021 | 19 | 2021 |
| Long-term neurotoxicity and quality of life in testicular cancer survivors—a nationwide cohort study J Lauritsen, M Bandak, M Kreiberg, JW Skøtt, T Wagner, JJ Rosenvilde, ... Journal of Cancer Survivorship 15, 509-517, 2021 | 17 | 2021 |
| Sexual function and quality of life in a national cohort of survivors of bilateral testicular cancer M Bandak, J Lauritsen, C Johansen, M Kreiberg, JW Skøtt, M Agerbaek, ... European urology focus 6 (4), 711-719, 2020 | 14 | 2020 |
| A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention) M Bandak, N Jørgensen, A Juul, J Lauritsen, M Kreiberg, PS Oturai, ... BMC cancer 17, 1-8, 2017 | 14 | 2017 |
| Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours–a systematic review JJ Rosenvilde, GL Pedersen, M Bandak, J Lauritsen, M Kreiberg, ... Acta Oncologica 60 (6), 695-703, 2021 | 13 | 2021 |
| Cohort profile: the Danish Testicular Cancer late treatment effects cohort (DaTeCa-LATE) M Kreiberg, M Bandak, J Lauritsen, JW Skøtt, NB Johansen, M Agerbaek, ... Frontiers in Oncology 8, 37, 2018 | 11 | 2018 |
| Influence of exercise in normal and hot ambient conditions on the pharmacokinetics of inhaled terbutaline in trained men M Kreiberg, V Becker, S Jessen, S Rzeppa, P Hemmersbach, V Backer, ... Scandinavian Journal of Medicine & Science in Sports 27 (7), 692-703, 2017 | 11 | 2017 |
| Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study T Wagner, BG Toft, B Engvad, J Lauritsen, M Kreiberg, M Bandak, ... BMJ open 9 (10), e033713, 2019 | 7 | 2019 |
| Effect of testosterone replacement therapy on quality of life and sexual function in testicular cancer survivors with mild leydig cell insufficiency: results from a randomized … EG Højer, M Kreiberg, C Dehlendorff, N Jørgensen, A Juul, J Lauritsen, ... Clinical Genitourinary Cancer 20 (4), 334-343, 2022 | 6 | 2022 |
| Paternity after treatment for testicular germ cell cancer: a Danish nationwide population-based cohort study M Bandak, A Jensen, C Dehlendorff, J Lauritsen, M Kreiberg, T Wagner, ... JNCI: Journal of the National Cancer Institute 114 (1), 149-155, 2022 | 6 | 2022 |
| Adverse health behaviours in long-term testicular cancer survivors: a Danish nationwide study M Kreiberg, M Bandak, J Lauritsen, T Wagner, J Rosenvilde, M Agerbaek, ... Acta Oncologica 60 (3), 361-369, 2021 | 6 | 2021 |
| Quality of life in long-term testicular cancer survivors with compensated leydig cell dysfunction JW Skøtt, J Lauritsen, M Kreiberg, G Daugaard, M Bandak Clinical Genitourinary Cancer 17 (1), e65-e71, 2019 | 6 | 2019 |
| Prognostic factors for relapse in patients with clinical stage I testicular seminoma: a nationwide, population-based cohort study T Wagner, BG Toft, J Lauritsen, M Bandak, IJ Christensen, B Engvad, ... Journal of Clinical Oncology 42 (1), 81-89, 2024 | 5 | 2024 |
| Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy L Priskorn, M Kreiberg, M Bandak, J Lauritsen, G Daugaard, JH Petersen, ... Human Reproduction 36 (9), 2443-2451, 2021 | 5 | 2021 |
Jakob LauritsenRigshospitalet, CopenhagenBestätigte E-Mail-Adresse bei regionh.dk
